FROM ACTIVE SURVEILLANCE TO ADVANCED THERAPIES
Hearing the words “You have prostate cancer” can stop anyone in their tracks.
For decades, many men believed that a diagnosis meant immediate surgery, radiation, or chemotherapy.
Today, that’s no longer true.
One of the biggest advances in prostate cancer care is recognizing that not every prostate cancer behaves the same way. Some grow so slowly they may never cause problems. Others are aggressive and require prompt treatment.
The goal is no longer simply treating cancer.
The goal is treating the right cancer in the right patient at the right time.
Not All Prostate Cancers Are Dangerous
Most prostate cancers grow slowly.
In fact, many older men die with prostate cancer rather than from it.
Doctors now classify prostate cancers into different risk categories based on:
- PSA level
- Gleason Grade Group (how abnormal the cancer cells look)
- MRI findings
- Biopsy results
- Size of the tumor
- Whether cancer has spread beyond the prostate
These factors help determine whether immediate treatment is needed—or whether careful observation is the safer choice.
Active Surveillance: Sometimes the Best Treatment Is No Treatment
Many men are surprised to learn that the first recommendation after a prostate cancer diagnosis may be…
Nothing.
Or more accurately:
Watch it carefully.
This approach is called active surveillance.
Rather than treating immediately, physicians monitor the cancer with:
- Regular PSA blood tests
- Periodic prostate MRIs
- Repeat biopsies when appropriate
- Physical examinations
Treatment begins only if there is evidence that the cancer is becoming more aggressive.
For men with low-risk prostate cancer, this approach has been shown to be very safe while avoiding unnecessary side effects.
Thousands of men have remained on active surveillance for many years without ever requiring surgery or radiation.
When Is Surgery Recommended?
For cancers that are more aggressive—or in younger, healthier men expected to live many more years—surgery may offer the best chance of cure.
The most common operation is a radical prostatectomy, which removes:
- The prostate gland
- Seminal vesicles
- Occasionally nearby lymph nodes
Today, most prostatectomies are performed using robotic-assisted minimally invasive surgery.
Although the surgeon controls every movement, robotic technology provides:
- Smaller incisions
- Less blood loss
- Less postoperative pain
- Faster recovery
- Shorter hospital stays
Experience matters. Outcomes for cancer control, urinary continence, and preservation of erectile function are generally better when surgery is performed by high-volume surgeons.
Radiation Therapy Has Also Improved
Radiation therapy has become much more precise than it was years ago. Modern techniques can deliver high doses directly to the prostate while limiting exposure to nearby healthy tissues.
Common options include:
External Beam Radiation Therapy (EBRT)
High-energy beams are directed at the prostate over several treatment sessions.
Newer techniques allow treatment to be highly targeted.
Stereotactic Body Radiation Therapy (SBRT)
SBRT delivers larger doses of radiation in only a few treatments.
For selected men, outcomes are comparable to longer treatment courses while offering greater convenience.
Brachytherapy
Small radioactive seeds are implanted directly into the prostate.
The seeds deliver radiation over time while minimizing exposure to surrounding tissues.
This option is often used alone for low-risk disease or combined with external radiation for higher-risk cancers.
Hormone Therapy
Prostate cancer cells often depend on testosterone to grow.
Hormone therapy—also called androgen deprivation therapy (ADT)—reduces testosterone levels or blocks its effects.
Hormone therapy may be recommended:
- Before radiation
- Along with radiation
- After recurrence
- For metastatic prostate cancer
Common side effects include:
- Hot flashes
- Fatigue
- Loss of muscle mass
- Weight gain
- Reduced sexual desire
- Bone loss
Regular exercise—especially resistance training—and adequate protein intake can help reduce some of these treatment-related effects.
What About Chemotherapy?
Chemotherapy is not commonly used for early-stage prostate cancer.
Instead, it is usually reserved for:
- Advanced disease
- Cancer that has spread
- Cancer no longer responding to hormone therapy
Newer chemotherapy regimens have improved survival for many men with advanced disease.
Newer Treatments Continue to Improve Outcomes
Prostate cancer treatment has advanced rapidly over the past decade.
Depending on the type of cancer and its genetic features, physicians may recommend:
Targeted Therapy
Certain medications work especially well in men whose cancers carry specific inherited or acquired genetic mutations, such as BRCA1 or BRCA2.
These therapies attack cancer cells while limiting damage to healthy tissue.
Immunotherapy
Some advanced prostate cancers can be treated by stimulating the body’s immune system to recognize and attack cancer cells.
Although not appropriate for every patient, immunotherapy has become an important option in selected cases.
Radiopharmaceutical Therapy
One of the newest advances involves radioactive medications that travel directly to prostate cancer cells throughout the body.
These treatments can improve survival and reduce pain in men with metastatic prostate cancer.
What Are the Chances of Survival?
This is the question every patient asks. The encouraging news is that outcomes are excellent when prostate cancer is detected early.
For cancer that remains confined to the prostate, the five-year relative survival rate is greater than 99%.
Even for men with more advanced disease, treatment options continue to improve, allowing many to live active, meaningful lives for years after diagnosis.
Choosing the Right Treatment
There is no single “best” treatment for every man.
Instead, decisions depend on:
- Your age
- Overall health
- Life expectancy
- Cancer stage
- Gleason Grade Group
- PSA level
- MRI findings
- Personal preferences
- Potential side effects
- Your goals and priorities
For many men, obtaining a second opinion from a urologist, radiation oncologist, or multidisciplinary prostate cancer center can provide valuable perspective before making a final decision.
Research Snapshot
Long-term studies have shown that active surveillance is a safe option for carefully selected men with low-risk prostate cancer, with very low rates of prostate cancer-related death over 10 to 15 years of follow-up. At the same time, advances in robotic surgery, image-guided radiation therapy, genetic testing, targeted therapies, and radiopharmaceuticals have significantly expanded treatment options and improved outcomes for men with higher-risk or advanced disease.
Dr. Mike’s Prescription
A diagnosis of prostate cancer should never be viewed as an emergency requiring an immediate decision. Take the time to understand your cancer, ask questions, review all of your treatment options, and consider a second opinion—especially if major surgery or radiation is being recommended. The best treatment is the one that matches both your cancer and your personal goals.
Did You Know?
The majority of men diagnosed with low-risk prostate cancer today do not go directly to surgery. Many safely choose active surveillance, allowing them to avoid or delay treatment-related side effects while remaining under close medical supervision.
Bottom Line
Prostate cancer treatment has changed dramatically over the past two decades. Today, physicians can tailor treatment to the biology of the cancer and the health of the individual patient. Many men never need immediate treatment, while those who do benefit from more precise surgery, improved radiation therapy, and innovative new medications. The most important step is not rushing into treatment—it is understanding your options and making an informed decision with your healthcare team.